Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Final Senate Action on “Domestic” Minibus (Including Ag/FDA) Set for Next Week Read More Analysis and Commentary STEVEN GROSSMAN 10/19/19 Analysis and Commentary STEVEN GROSSMAN 10/19/19 Is Another Shutdown a Real Possibility? Read More Analysis and Commentary STEVEN GROSSMAN 10/5/19 Analysis and Commentary STEVEN GROSSMAN 10/5/19 Full-Year CR: Better Than a Shutdown, But ... Read More Advocacy at a Glance STEVEN GROSSMAN 4/19/19 Advocacy at a Glance STEVEN GROSSMAN 4/19/19 Budget and Appropriations: Progress But No Clear Path Forward Read More Analysis and Commentary STEVEN GROSSMAN 3/22/19 Analysis and Commentary STEVEN GROSSMAN 3/22/19 Sorting Out the Details of the President's FY 20 Request Read More Advocacy at a Glance STEVEN GROSSMAN 3/1/19 Advocacy at a Glance STEVEN GROSSMAN 3/1/19 Hill Requests Are Due: Now Through Early April Read More Analysis and Commentary STEVEN GROSSMAN 2/8/19 Analysis and Commentary STEVEN GROSSMAN 2/8/19 The Questions -- and the Answers -- Continue! Read More STEVEN GROSSMAN 2/8/19 STEVEN GROSSMAN 2/8/19 CR/Shutdown Countdown: One Week to Go Read More Analysis and Commentary STEVEN GROSSMAN 2/1/19 Analysis and Commentary STEVEN GROSSMAN 2/1/19 Members' Questions Are Still Flowing In Read More Advocacy at a Glance STEVEN GROSSMAN 2/1/19 Advocacy at a Glance STEVEN GROSSMAN 2/1/19 February 15 Is the New Deadline; Negotiations Begin Read More Analysis and Commentary STEVEN GROSSMAN 1/26/19 Analysis and Commentary STEVEN GROSSMAN 1/26/19 Shutdown- and BA-Related Q&As Continued Read More Advocacy at a Glance STEVEN GROSSMAN 1/26/19 Advocacy at a Glance STEVEN GROSSMAN 1/26/19 Possible Temporary End to Shutdown Announced. Read More STEVEN GROSSMAN 1/18/19 STEVEN GROSSMAN 1/18/19 The Shutdown: Media Snippets and Commentary Read More Advocacy at a Glance STEVEN GROSSMAN 1/18/19 Advocacy at a Glance STEVEN GROSSMAN 1/18/19 Alliance Works to be a Leading Source of Concern on Shutdown Read More STEVEN GROSSMAN 1/11/19 STEVEN GROSSMAN 1/11/19 The Shutdown Continues: More Qs; More As Read More STEVEN GROSSMAN 1/7/19 STEVEN GROSSMAN 1/7/19 Alliance Releases FDA Shutdown Toolkit Read More Analysis and Commentary STEVEN GROSSMAN 1/4/19 Analysis and Commentary STEVEN GROSSMAN 1/4/19 Can the Alliance Help to End the Shutdown? No and Yes! Read More Advocacy at a Glance STEVEN GROSSMAN 1/4/19 Advocacy at a Glance STEVEN GROSSMAN 1/4/19 Soon To Be Released: Alliance’s FDA Shutdown Toolkit Read More Older Posts
Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More
Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More
Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Final Senate Action on “Domestic” Minibus (Including Ag/FDA) Set for Next Week Read More
Analysis and Commentary STEVEN GROSSMAN 10/19/19 Analysis and Commentary STEVEN GROSSMAN 10/19/19 Is Another Shutdown a Real Possibility? Read More
Analysis and Commentary STEVEN GROSSMAN 10/5/19 Analysis and Commentary STEVEN GROSSMAN 10/5/19 Full-Year CR: Better Than a Shutdown, But ... Read More
Advocacy at a Glance STEVEN GROSSMAN 4/19/19 Advocacy at a Glance STEVEN GROSSMAN 4/19/19 Budget and Appropriations: Progress But No Clear Path Forward Read More
Analysis and Commentary STEVEN GROSSMAN 3/22/19 Analysis and Commentary STEVEN GROSSMAN 3/22/19 Sorting Out the Details of the President's FY 20 Request Read More
Advocacy at a Glance STEVEN GROSSMAN 3/1/19 Advocacy at a Glance STEVEN GROSSMAN 3/1/19 Hill Requests Are Due: Now Through Early April Read More
Analysis and Commentary STEVEN GROSSMAN 2/8/19 Analysis and Commentary STEVEN GROSSMAN 2/8/19 The Questions -- and the Answers -- Continue! Read More
Analysis and Commentary STEVEN GROSSMAN 2/1/19 Analysis and Commentary STEVEN GROSSMAN 2/1/19 Members' Questions Are Still Flowing In Read More
Advocacy at a Glance STEVEN GROSSMAN 2/1/19 Advocacy at a Glance STEVEN GROSSMAN 2/1/19 February 15 Is the New Deadline; Negotiations Begin Read More
Analysis and Commentary STEVEN GROSSMAN 1/26/19 Analysis and Commentary STEVEN GROSSMAN 1/26/19 Shutdown- and BA-Related Q&As Continued Read More
Advocacy at a Glance STEVEN GROSSMAN 1/26/19 Advocacy at a Glance STEVEN GROSSMAN 1/26/19 Possible Temporary End to Shutdown Announced. Read More
STEVEN GROSSMAN 1/18/19 STEVEN GROSSMAN 1/18/19 The Shutdown: Media Snippets and Commentary Read More
Advocacy at a Glance STEVEN GROSSMAN 1/18/19 Advocacy at a Glance STEVEN GROSSMAN 1/18/19 Alliance Works to be a Leading Source of Concern on Shutdown Read More
Analysis and Commentary STEVEN GROSSMAN 1/4/19 Analysis and Commentary STEVEN GROSSMAN 1/4/19 Can the Alliance Help to End the Shutdown? No and Yes! Read More
Advocacy at a Glance STEVEN GROSSMAN 1/4/19 Advocacy at a Glance STEVEN GROSSMAN 1/4/19 Soon To Be Released: Alliance’s FDA Shutdown Toolkit Read More
